Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (22989)	7/9/1998 5:15:00 PM
From: WTDEC	Respond to of 32384

PB, thanks for the information. We have all been patiently waiting for that. No need to be sorry. Regards, Walter

To: Pseudo Biologist who wrote (22989)	7/9/1998 5:22:00 PM
From: celeryroot.com	Respond to of 32384

thx PB Fugazi I thought you were camped out for us

To: Pseudo Biologist who wrote (22989)	7/9/1998 8:58:00 PM
From: Henry Niman	Respond to of 32384

Here's the News of the Week summary from Science: DRUG DEVELOPMENT: Small Molecule Fills Hormone's Shoes Marcia Barinaga Drug companies have long sought small compounds that mimic the effects of protein drugs yet evade breakdown in the digestive tract, but the small chemicals, which might be just 1/50 of a protein's size, seemed too puny to turn on the proteins' surface receptors. Now, on page 257, researchers report their discovery of a small molecule that activates the receptor for granulocyte-colony-stimulating factor, a cytokine that is commonly used to boost patients' immune systems after chemotherapy. Although the new compound works in mice but not humans, it is being heralded as evidence that the right small molecule can indeed fill a protein hormone's shoes.